They developed an in vitro endothelial-tumor cell bilayer model and demonstrated that CCL21-FA-UCNPs@mesoporous silica could selectively target folate receptor (FR)-expressing OVCAR-3 cells. The gene discussed is CCL21; the disease is neoplasm.